Ụlọ Ọrụ Na-ahụ Maka N'Ịntanet, Canada Nweta Ụlọ, European Delivery Delivery

11α-Hydroxy canrenone ntụ ntụ (192569-17-8)

Rating:
2.75 si 5 dabere na 4 ahịa Fim
SKU: 192569-17-8. Category:

AASraw nọ na njikọ na ike imepụta site na gram ruo n'usoro nke 11α-Hydroxy canrenone Powder (192569-17-8), n'okpuru ụkpụrụ CGMP na njikwa njikwa njiri ike.

Product Description

Ihe nkiri 11α-Hydroxy canrenone Powder (192569-17-8)


11α-Hydroxy canrenone ntụ ntụ (192569-17-8) Specification:

Ngwurugwu Chemical: Product Name:Cananone 11α-Hydroxy
Raw 11α-Hydroxy canrenone ntụ ntụ (192569-17-8) hplc≥98% | AASraw Cas Mba: 192569-17-8
molekụla Formula: C22H28O4
molekụla arọ: 356.46
Synonyms: 11-alfa-Hydroxycarvenone
nchekwa: Akọrọ, ọchịchịrị · ma na 0 - 4 C maka obere oge (ụbọchị ruo izu) ma ọ bụ -20 C ruo ogologo oge (ọnwa ruo afọ).
Akwụkwọ edemede (COA & HPLC wdg): dị

11α-Hydroxy canrenone ntụ ntụ (192569-17-8) Daha:

11α-Hydroxy canrenone na-arụ ọrụ dị ka Canrenone bụ aldosterone antagonist nwere ọrụ mkpụrụ ndụ na-eme ka ọnụnọ potassium na-adị. Canrenone na-emegide ọgwụ aldosterone n'ụzọ dị mma na onye na-anabata mineralralocorticoid na akụrụ, si otú ahụ na-abawanye sodium excretion na igbochi potassium excretion.Canrenone ka a na-enwetacha ike dịka antimineralocorticoid na-emetụta spironolactone, mana ọ dị obere ma dị irè dịka antiandrogen.11α-Hydroxyproge steroid na metabolite nke progesterone.It bụ antiandrogen na-adịghị ike, ọ nweghịkwa ọrụ androgenic, estrogenic, na ọrụ progestogenic.

Ntughari:

  • Jürg Müller (6 Disemba 2012). Iwu nke Aldosterone Biosynthesis: Ahụike na ọgwụgwọ ọrịa. Sayensị Scienceer na Business. p. 164-. ISBN 978-3-642-83120-1.
  • Ford, Donald H. (1954). “NSO NKE 11α-HYDROXYPROGESTERONE NA NKWUKWU NGWALROR NKWALKWỌ NGW ANDKWỌ NGW *KWỌ NGW *R * *”. Akwụkwọ akụkọ nke Clinical Endocrinology & Metabolism. 14 (10): 1268–1270. doi: 10.1210 / jcem-14-10-1268. ISSN 0021-972X.
  • Souness GW, Latif SA, Laurenzo JL, Morris DJ (1995). "11 alfa- na 11 beta-hydroxyprogesterone, ndị na - egbochi 11 beta-hydroxysteroid dehydrogenase (isoforms 1 na 2), na-egosi akara mineralocorticoid na corticosterone na oke ADX". Endocrinology. 136 (4): 1809–12.

NKWUP ANDTA NA NKWU:

A na-ere Ihe Nke A Maka Nchọpụta Naanị. Usoro irere tinye. Ọbụghị maka Oriri mmadu, ma ọ bụ ọgwụ, ọgwụ anụ, ma ọ bụ nke ụlọ.


COA

HNMR

10161-35-8 Trenbolone na HNMR adanthate

Ezi ntụziaka

Trenbolone enanthate Agbara ntụ ntụ Ntụziaka:

Ịjụ ajụjụ maka ndị na - anọchite anya anyị (CSR) maka nkọwa, maka amaokwu gị.

Ntughari & akwukwo akwukwo

Ihe niile gbasara Trenbolone Enanthate ntụ ntụ

Otu esi eji Trenbololone Ntụziaka na-ejikọ Trenbolone Enanthate Powder 2019

Ihe Nduzi kachasị: Otu esi eji Trenbololone Ntụziaka iji merie Trenbolone Enanthate ntụ ntụ n'ime mmanụ [2019]

References:

William Llewellyn, Nri oriri na ala, Anabolics, Peeji nke 491 - 499, 618, 724, 2011.

Kickman, AT, Pharmacology of Anabolic Steroids, British Journal of Pharmacology, PMC 2439524, Online, 2018.

Wilson, VS, Lambright, C., Ostby, J., Grey Jr, LE, Na Vitro na na Vivo Effects nke 17beta-Trenbolone: ​​a Feedlot Effluent Contaminant, Toxicological Sciences, 2002.

Yarrow, JF, McCoy, SC, Borst, SE, Ụdị Nhọrọ na Nlekọta Ọgwụgwụ Ngwa nke Trenbolone: ​​Ụbụrụ Anabolic nwere ike na Androgenic na Ọrụ Estrogenic, PublishMed Publications, Online, 2010.

Ojasoo, Raynaud., Ndị Na-ahụ Maka Ọgwụ Na-ahụ Maka Ụkpụrụ Na-ahụ Maka Ọgwụ Na-ahụ Maka Nchọpụta, Research Research, 1978.